For the new study, researchers used a “secret-shopper” method to attempt to schedule an appointment for a patient weighing ...

Thousands of NHS patients are believed to be missing out. And with the NHS tightly restricting access, some working in the ...

Experts in Europe are concerned about what the global GLP-1 agonist excitement could mean for childhood obesity, which can ...

In the SIBAMATE study, more than 60% of patients lost at least 5% of body weight after 3 months of using ...

East Carroll Parish had the highest prevalence of obesity, while St. Tammany and Lafayette parishes had the lowest. How did ...

High sugar intake is concerning: 21 states and union territories exceeded the national recommendations of less than 5% added ...

A large genome-wide analysis reports that common obesity traits share, and in some cases drive, risk for diabetic kidney ...

Five months after ending development of its own obesity treatment, Pfizer is accelerating its push into the rapidly growing ...

Patients weighing more than 450 lb face considerable limitations when attempting to access specialty care, according to a ...

"Pfizer’s obesity bet shows 14.1% weight loss in Phase IIb trial" was originally created and published by Clinical Trials ...

Closing adds $5 million in marketable securities, strengthens financial position, and complements MIRA's advancing programs ...

Metsera's MET-097i cut weight up to 14% in Phase 2b trials, with manageable side effects, as the company targets a global ...